ipilimumab
bms
['melanoma', 'solid tumor', 'immune therap']
the first t cell #immunotherapy phase 3 clinical trial in solid tumors to be presented at #esmo22, presidential symposium i today at 17:20. potentially practice changing results in #melanoma from and ! 
Bridging the gap between discovery and clinical implementation in #cancer #immunotherapy #immunooncology at @HerlevGentofte . SoMe manager @doniamarco